ACCF/AHA Practice Guideline Practice Guidelines 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
暂无分享,去创建一个
Jeffrey L. Anderson | W. Stevenson | C. Yancy | E. Ohman | J. Halperin | Sidney C. Smith | R. Page | C. Buller | N. Albert | J. Hochman | R. Guyton | M. Creager | F. Kushner | S. Ettinger | L. Tarkington | Rick A. Nishimura
[1] A. Thanopoulou,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[2] M. Davidson,et al. Correction to the 2010 Report on the Diagnosis and Classification of Diabetes , 2010, Diabetes Care.
[3] D. Mozaffarian,et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.
[4] V. Basevi. Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.
[5] J. Danesh,et al. B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies , 2009, Circulation.
[6] V. Fuster,et al. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. , 2009, Atherosclerosis.
[7] D. Berman,et al. Screening for coronary artery disease in diabetic patients: A commentary , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[8] D. Lloyd‐Jones,et al. Systematic Examination of the Updated Framingham Heart Study General Cardiovascular Risk Profile , 2009, Circulation.
[9] J. Danesh,et al. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. , 2009, JAMA.
[10] K. P. Kim,et al. Coronary artery calcification screening: estimated radiation dose and cancer risk. , 2009, Archives of internal medicine.
[11] Y. Yamasaki,et al. Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[12] Ian J. Brown,et al. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease. , 2009, JAMA.
[13] M. Pencina,et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.
[14] H. Ishwaran,et al. Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms. , 2009, American heart journal.
[15] D. Schauer,et al. NCRP REPORT NO. 160, IONIZING RADIATION EXPOSURE OF THE POPULATION OF THE UNITED STATES, MEDICAL EXPOSURE—ARE WE DOING LESS WITH MORE, AND IS THERE A ROLE FOR HEALTH PHYSICISTS? , 2009, Health physics.
[16] Michael J. Pencina,et al. Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.
[17] Martin J Graves,et al. The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. , 2009, Journal of the American College of Cardiology.
[18] Yasuo Ohashi,et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. , 2009, JAMA.
[19] R. Gibbons,et al. Stress single photon emission computed tomography for detection of coronary artery disease and risk stratification of asymptomatic patients at moderate risk , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[20] Jeroen J. Bax,et al. Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[21] L. Peltonen,et al. Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease , 2009, Genome Medicine.
[22] S. Mora. Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. , 2009, Circulation.
[23] F. Harrell,et al. Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association , 2009, Circulation.
[24] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[25] J. Lau,et al. Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes , 2009, Annals of Internal Medicine.
[26] Jeroen J. Bax,et al. Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus , 2009, European Journal of Nuclear Medicine and Molecular Imaging.
[27] T. Gill,et al. Independent Association of HbA1c and Incident Cardiovascular Disease in People Without Diabetes , 2009, Obesity.
[28] C. Anderson,et al. Proteinuria and stroke: a meta-analysis of cohort studies. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[29] S. Achenbach,et al. Estimated radiation dose associated with cardiac CT angiography. , 2009, JAMA.
[30] L. Smeeth,et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. , 2009, International journal of epidemiology.
[31] P. Ridker,et al. Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study. , 2009, Clinical chemistry.
[32] S. Harada. [ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery]. , 2009, Masui. The Japanese journal of anesthesiology.
[33] D. Mozaffarian,et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2009, Circulation.
[34] D. Berman,et al. Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[35] Nancy R Cook,et al. Cardiovascular Disease Risk Prediction With and Without Knowledge of Genetic Variation at Chromosome 9p21.3 , 2009, Annals of Internal Medicine.
[36] Grant D. Huang,et al. Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.
[37] M. Budoff,et al. Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect , 2009, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[38] R. Kronmal,et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). , 2009, Journal of the American College of Cardiology.
[39] A. Classification,et al. Standards of Medical Care in Diabetes—2009 , 2009, Diabetes Care.
[40] C. Furberg,et al. Prevalence, Prognosis, and Implications of Isolated Minor Nonspecific ST-Segment and T-Wave Abnormalities in Older Adults: Cardiovascular Health Study , 2008, Circulation.
[41] D. Lloyd‐Jones,et al. Who exceeds ATP-III risk thresholds? Systematic examination of the effect of varying age and risk factor levels in the ATP-III risk assessment tool. , 2008, Preventive medicine.
[42] N. Paynter,et al. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.
[43] M. Hlatky. Expanding the orbit of primary prevention--moving beyond JUPITER. , 2008, The New England journal of medicine.
[44] P. Libby,et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.
[45] Qingbo Xu,et al. Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10-year cardiovascular and non-cardiovascular mortality: results from the Bruneck study. , 2008, European heart journal.
[46] B. Balkau,et al. Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance. The DESIR Study , 2008, Journal of hypertension.
[47] D. de Zeeuw,et al. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. , 2008, American journal of epidemiology.
[48] C. Becker,et al. Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: A prospective study in 716 patients over 8 years , 2008, BMC cardiovascular disorders.
[49] M. Jardine,et al. The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis , 2008, PLoS medicine.
[50] M. McQueen,et al. Requesting and interpreting urine albumin measurements in the primary health care setting. , 2008, Clinical chemistry.
[51] Mathias M. Müller,et al. Postanalytical external quality assessment of urine albumin in primary health care: an international survey. , 2008, Clinical chemistry.
[52] J. Danesh,et al. C‐reactive protein and coronary heart disease: a critical review , 2008, Journal of internal medicine.
[53] S. Humphries,et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. , 2008, European heart journal.
[54] E. Barrett-Connor,et al. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. , 2008, Journal of the American College of Cardiology.
[55] R. Sacco,et al. Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS). , 2008, American heart journal.
[56] Jun Li,et al. Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study. , 2008, Human molecular genetics.
[57] J. J. Rivera,et al. Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. , 2008, Journal of the American College of Cardiology.
[58] A Hofman,et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.
[59] M. Kubo,et al. High-Sensitivity C-Reactive Protein and Coronary Heart Disease in a General Population of Japanese: The Hisayama Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[60] A. Khera,et al. Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study. , 2008, Atherosclerosis.
[61] J. Dartigues,et al. Distension of the Carotid Artery and Risk of Coronary Events: The Three-City Study , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[62] Leslee J Shaw,et al. Coronary artery calcium to predict all-cause mortality in elderly men and women. , 2008, Journal of the American College of Cardiology.
[63] Riccardo Pini,et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. , 2008, Journal of the American College of Cardiology.
[64] Moyses Szklo,et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Archives of internal medicine.
[65] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[66] S. Sharp,et al. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events? , 2008, Archives of internal medicine.
[67] M. Pencina,et al. Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort--invited commentary. , 2008, Archives of internal medicine.
[68] A. Lindsay,et al. Form to function: current and future roles for atherosclerosis imaging in drug development , 2008, Nature Reviews Drug Discovery.
[69] W. Bodmer,et al. Common and rare variants in multifactorial susceptibility to common diseases , 2008, Nature Genetics.
[70] Sameer Bansilal,et al. Atherosclerosis Inflammation Imaging with 18F-FDG PET: Carotid, Iliac, and Femoral Uptake Reproducibility, Quantification Methods, and Recommendations , 2008, Journal of Nuclear Medicine.
[71] D. O'Connor,et al. Hereditary Determinants of Human Hypertension: Strategies in the Setting of Genetic Complexity , 2008, Hypertension.
[72] K. Olden,et al. The prevalence of metabolic syndrome among US women of childbearing age. , 2008, American journal of public health.
[73] B. Astor,et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. , 2008, American journal of epidemiology.
[74] Hanna E Bloomfield,et al. Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men. , 2008, The American journal of cardiology.
[75] Anders Larsson,et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. , 2008, The New England journal of medicine.
[76] Ramachandran S Vasan,et al. Cross-Sectional Relations of Digital Vascular Function to Cardiovascular Risk Factors in the Framingham Heart Study , 2008, Circulation.
[77] Silvio E. Inzucchi,et al. Standards of Medical Care in Diabetes—2008 , 2008, Diabetes Care.
[78] M. Hanefeld,et al. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. , 2008, Journal of the American College of Cardiology.
[79] P. O'Malley,et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. , 2008, Journal of the American College of Cardiology.
[80] William R Hiatt,et al. A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life. , 2008, Journal of the American College of Cardiology.
[81] L. Kuller,et al. Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68-102: the Cardiovascular Health Study. , 2008, Atherosclerosis.
[82] R. Blumenthal,et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. , 2008, The American journal of cardiology.
[83] G. Mancia,et al. Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician? , 2008, American journal of hypertension.
[84] Frank J. Rybicki,et al. Interrelation of Coronary Calcification, Myocardial Ischemia, and Outcomes in Patients With Intermediate Likelihood of Coronary Artery Disease: A Combined Positron Emission Tomography/Computed Tomography Study , 2008, Circulation.
[85] R. Kronmal,et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. , 2008, The New England journal of medicine.
[86] Olle Melander,et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. , 2008, The New England journal of medicine.
[87] K. Offit. Genomic profiles for disease risk: predictive or premature? , 2008, JAMA.
[88] Paul G Shekelle,et al. Delivery of genomic medicine for common chronic adult diseases: a systematic review. , 2008, JAMA.
[89] L. Wann,et al. ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, , 2008, Journal of the American College of Cardiology.
[90] Garrett Fitzmaurice,et al. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort , 2008, The Lancet.
[91] Circe W. Tsui,et al. Random Plasma Glucose in Serendipitous Screening for Glucose Intolerance: Screening for Impaired Glucose Tolerance Study 2 , 2008, Journal of General Internal Medicine.
[92] M. G. Modena,et al. Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. , 2008, Journal of the American College of Cardiology.
[93] E. Barrett-Connor,et al. Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study. , 2008, Journal of the American College of Cardiology.
[94] M. Pepys. C-reactive protein is neither a marker nor a mediator of atherosclerosis , 2008, Nature Clinical Practice Nephrology.
[95] S. Humphries,et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. , 2008, Clinical chemistry.
[96] Thomas J. Wang,et al. The search for new cardiovascular biomarkers , 2008, Nature.
[97] Zahi A. Fayad,et al. Imaging of atherosclerotic cardiovascular disease , 2008, Nature.
[98] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[99] T. Nakajima,et al. Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations , 2008, Journal of Human Genetics.
[100] R. Kronmal,et al. Risk Factor Associations With the Presence of a Lipid Core in Carotid Plaque of Asymptomatic Individuals Using High-Resolution MRI: The Multi-Ethnic Study of Atherosclerosis (MESA) , 2008, Stroke.
[101] Christopher B. Kendall,et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[102] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[103] L. Kuller,et al. Coronary artery calcium, carotid artery wall thickness, and cardiovascular disease outcomes in adults 70 to 99 years old. , 2008, The American journal of cardiology.
[104] T. Hansen,et al. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex , 2008, Journal of hypertension.
[105] M. Kattan,et al. An Externally Validated Model for Predicting Long-Term Survival after Exercise Treadmill Testing in Patients with Suspected Coronary Artery Disease and a Normal Electrocardiogram , 2007, Annals of Internal Medicine.
[106] David M Herrington,et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). , 2007, Archives of internal medicine.
[107] B. Astor,et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study. , 2007, Archives of internal medicine.
[108] Yuh-Min Song,et al. Faculty Opinions recommendation of Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. , 2007 .
[109] P. Libby,et al. Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein. , 2007, The American journal of cardiology.
[110] R. Myerburg,et al. Electrocardiograms Should Be Included in Preparticipation Screening of Athletes , 2007, Circulation.
[111] J. Coresh,et al. Prevalence of chronic kidney disease in the United States. , 2007, JAMA.
[112] P. Okin,et al. In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study , 2007, Hypertension.
[113] S. Pocock,et al. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.
[114] T. Marteau,et al. Is attributing smoking to genetic causes associated with a reduced probability of quit attempt success? A cohort study , 2007, Addiction.
[115] Mika Kähönen,et al. Association of Pathobiologic Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns Study). , 2007, The American journal of cardiology.
[116] R. D'Agostino,et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study , 2007, BMC Medical Genetics.
[117] Randall C. Thompson,et al. Radiation Dose to Patients From Cardiac Diagnostic Imaging , 2007, Circulation.
[118] D. Berman,et al. Use of coronary calcium scanning for predicting inducible myocardial ischemia: Influence of patients’ clinical presentation , 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[119] Kari Stefansson,et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. , 2007, Science.
[120] M. Pencina,et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. , 2007, JAMA.
[121] J. Ornato,et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie , 2007, Journal of the American College of Cardiology.
[122] M. Nieminen,et al. Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death: The LIFE Study , 2007, Circulation.
[123] C. Gieger,et al. Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.
[124] P. Ridker,et al. Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. , 2007, The American journal of medicine.
[125] Jeroen J. Bax,et al. Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes , 2007, Heart.
[126] M. Hanefeld,et al. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis. , 2007, The New England journal of medicine.
[127] Richard B. Devereux,et al. Central Pressure More Strongly Relates to Vascular Disease and Outcome Than Does Brachial Pressure: The Strong Heart Study , 2007, Hypertension.
[128] P. Greenland,et al. Framingham risk score and prediction of coronary heart disease death in young men. , 2007, American heart journal.
[129] Simon Capewell,et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. , 2007, The New England journal of medicine.
[130] S. Michie,et al. Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking , 2007, Clinical genetics.
[131] F. Hsu,et al. Brachial Flow-Mediated Dilation Predicts Incident Cardiovascular Events in Older Adults: The Cardiovascular Health Study , 2007, Circulation.
[132] Jeroen J. Bax,et al. Prognostic significance of myocardial ischemia during dobutamine stress echocardiography in asymptomatic patients with diabetes mellitus and no prior history of coronary events. , 2007, The American journal of cardiology.
[133] J. Cohn,et al. Arterial stiffness as a risk factor for coronary atherosclerosis , 2007, Current atherosclerosis reports.
[134] I. Kullo,et al. Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification. , 2007, Journal of the American College of Cardiology.
[135] W. Knowler,et al. Factors Associated With Diabetes Onset During Metformin Versus Placebo Therapy in the Diabetes Prevention Program , 2007, Diabetes.
[136] Y. Ostchega,et al. Prevalence of Peripheral Arterial Disease and Risk Factors in Persons Aged 60 and Older: Data from the National Health and Nutrition Examination Survey 1999–2004 , 2007, Journal of the American Geriatrics Society.
[137] D. Berman,et al. Clinical outcomes after both coronary calcium scanning and exercise myocardial perfusion scintigraphy. , 2007, Journal of the American College of Cardiology.
[138] J. Kaufman,et al. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization , 2007, BMC cardiovascular disorders.
[139] Rowena J Dolor,et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. , 2007, Journal of the American College of Cardiology.
[140] W. Ghali,et al. A comprehensive view of sex-specific issues related to cardiovascular disease , 2007, Canadian Medical Association Journal.
[141] Philip Greenland,et al. Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. , 2007, JAMA.
[142] Jonathan C. Cohen,et al. A Common Allele on Chromosome 9 Associated with Coronary Heart Disease , 2007, Science.
[143] N. Cook. Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction , 2007, Circulation.
[144] N. Cook,et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. , 2007, JAMA.
[145] Nicholas J Wareham,et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. , 2007, Journal of the American College of Cardiology.
[146] R. Karas,et al. Assessment of peripheral vascular endothelial function in the ambulatory setting , 2007, Vascular medicine.
[147] I. Kullo,et al. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. , 2007, Mayo Clinic proceedings.
[148] W. Knowler,et al. Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[149] J. Danesh,et al. Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. , 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[150] Matthias W. Lorenz,et al. Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis , 2007, Circulation.
[151] I. Kullo,et al. Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults , 2007, Journal of Human Hypertension.
[152] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[153] N. Wareham,et al. Glycated hemoglobin as a marker of cardiovascular risk , 2006, Current opinion in lipidology.
[154] D. Vinereanu,et al. Risk factors for atherosclerotic disease: present and future. , 2006, Herz.
[155] O. Williams,et al. Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score: the CARDIA study. , 2006, Archives of internal medicine.
[156] H. Struijker‐Boudier,et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. , 2006, European heart journal.
[157] E. Boyko,et al. Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[158] E. O’Brien,et al. Ambulatory arterial stiffness index predicts stroke in a general population , 2006, Journal of hypertension.
[159] Jonathan G Goldin,et al. Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiolog , 2006, Circulation.
[160] Maurizio Schiavon,et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. , 2006, JAMA.
[161] J. Strong,et al. Pathobiological Determinants of Atherosclerosis in Youth Risk Scores Are Associated With Early and Advanced Atherosclerosis , 2006, Pediatrics.
[162] R. Detrano,et al. Carotid vulnerable lesions are related to accelerated recurrence for cerebral infarction magnetic resonance imaging study. , 2006, Academic radiology.
[163] M. Laakso,et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.
[164] G. Peters,et al. Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all , 2006, Nature Reviews Molecular Cell Biology.
[165] Jeroen J. Bax,et al. The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes. , 2006, Journal of the American College of Cardiology.
[166] H. Parving,et al. Microalbuminuria as an early marker for cardiovascular disease. , 2006, Journal of the American Society of Nephrology : JASN.
[167] Juan P Casas,et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization. , 2006, International journal of epidemiology.
[168] B. Horne,et al. Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. , 2006, American heart journal.
[169] Eric Boerwinkle,et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. , 2006, Archives of internal medicine.
[170] Nancy R Cook,et al. The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women , 2006, Annals of Internal Medicine.
[171] C. Pascale,et al. Prevalence of silent myocardial ischaemia in new‐onset middle‐aged Type 2 diabetic patients without other cardiovascular risk factors , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[172] Peter Jüni,et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. , 2006, American heart journal.
[173] F. Lin,et al. Prognostic Implications of Left Ventricular Mass Among Hispanics: The Northern Manhattan Study , 2006, Hypertension.
[174] P. Ridker,et al. Valsartan, Blood Pressure Reduction, and C-Reactive Protein: Primary Report of the Val-MARC Trial , 2006, Hypertension.
[175] R. Rodeheffer,et al. Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide: Biomarkers for Mortality in a Large Community-Based Cohort Free of Heart Failure , 2006, Hypertension.
[176] J. Laukkanen,et al. Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men. , 2006, European heart journal.
[177] T Fahey,et al. Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review , 2006, Heart.
[178] M. Budoff,et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. , 2006, Atherosclerosis.
[179] A. Newman,et al. The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study , 2006, International Journal of Obesity.
[180] L. Shaw,et al. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. , 2006, European heart journal.
[181] Yan Li,et al. Ambulatory Arterial Stiffness Index as a Predictor of Cardiovascular Mortality in the Dublin Outcome Study , 2006, Hypertension.
[182] Chun Yuan,et al. Association Between Carotid Plaque Characteristics and Subsequent Ischemic Cerebrovascular Events: A Prospective Assessment With MRI—Initial Results , 2006, Stroke.
[183] R. D'Agostino,et al. Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age , 2006, Circulation.
[184] Albert Hofman,et al. Arterial Stiffness and Risk of Coronary Heart Disease and Stroke: The Rotterdam Study , 2006, Circulation.
[185] Tine Willum Hansen,et al. Prognostic Value of Aortic Pulse Wave Velocity as Index of Arterial Stiffness in the General Population , 2006, Circulation.
[186] Carl J Pepine,et al. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. , 2006, Journal of the American College of Cardiology.
[187] Y. Lacourciére,et al. Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging. , 2006, The Canadian journal of cardiology.
[188] E. Fishman,et al. Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease. , 2006, The American journal of cardiology.
[189] A. Newman,et al. Mortality and Cardiovascular Risk Across the Ankle-Arm Index Spectrum: Results From the Cardiovascular Health Study , 2006, Circulation.
[190] M. Abney,et al. The sex-specific genetic architecture of quantitative traits in humans , 2006, Nature Genetics.
[191] J. Murabito,et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. , 2005, JAMA.
[192] Mark Woodward,et al. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies , 2005, BMJ : British Medical Journal.
[193] Lauri Toivonen,et al. Electrocardiographic Strain Pattern and Prediction of New-Onset Congestive Heart Failure in Hypertensive Patients: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study , 2005, Circulation.
[194] H. Matsubara,et al. Acute myocardial infarction in young Japanese adults. , 2005, Circulation journal : official journal of the Japanese Circulation Society.
[195] P. McKeigue,et al. Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: a prospective cohort study. , 2005, Journal of the American Society of Nephrology : JASN.
[196] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[197] Chun Yuan,et al. In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.
[198] P. Greenland,et al. When is a new prediction marker useful? A consideration of lipoprotein-associated phospholipase A2 and C-reactive protein for stroke risk. , 2005, Archives of internal medicine.
[199] M. Pencina,et al. C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. , 2005, Archives of internal medicine.
[200] Paolo Raggi,et al. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. , 2005, Journal of the American College of Cardiology.
[201] Ferdinand K. Hui,et al. Female breast radiation exposure during CT pulmonary angiography. , 2005, AJR. American journal of roentgenology.
[202] M. Lauer,et al. Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol). , 2005, The American journal of cardiology.
[203] B. Estour,et al. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. , 2005, Diabetes care.
[204] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[205] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[206] Irwin Feuerstein,et al. Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project. , 2005, Journal of the American College of Cardiology.
[207] B. Howard,et al. C-Reactive Protein as a Predictor of Cardiovascular Risk in a Population With a High Prevalence of Diabetes: The Strong Heart Study , 2005, Circulation.
[208] R. Gibbons,et al. Improved Survival in Asymptomatic Diabetic Patients With High-Risk Spect Imaging Treated With Coronary Artery Bypass Grafting , 2005, Circulation.
[209] D. Levy,et al. Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.
[210] M. Lauer,et al. Exercise Testing in Asymptomatic Adults: A Statement for Professionals From the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention , 2005, Circulation.
[211] A. Hofman,et al. Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly , 2005, Circulation.
[212] Y. Arad,et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. , 2005, Journal of the American College of Cardiology.
[213] P. Hildebrandt,et al. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. , 2005, JAMA.
[214] A. Sharrett,et al. Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis. , 2005, American journal of epidemiology.
[215] E. Lakatta,et al. Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults , 2005, Circulation.
[216] D. Grobbee,et al. Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations? , 2005, Journal of the American College of Cardiology.
[217] G. Eknoyan,et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.
[218] H. Resnick,et al. Prevalence of elevated ankle-brachial index in the United States 1999 to 2002. , 2005, The American journal of medicine.
[219] Thomas P. Erlinger,et al. Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey , 2005, PLoS medicine.
[220] Chun Yuan,et al. Presence of Intraplaque Hemorrhage Stimulates Progression of Carotid Atherosclerotic Plaques: A High-Resolution Magnetic Resonance Imaging Study , 2005, Circulation.
[221] A. Zalewski,et al. Role of Lipoprotein-Associated Phospholipase A2 in Atherosclerosis: Biology, Epidemiology, and Possible Therapeutic Target , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[222] P. Pattynama,et al. Carotid plaque composition and cerebral infarction: MR imaging study. , 2005, AJNR. American journal of neuroradiology.
[223] Philip J. Barter,et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. , 2005, The New England journal of medicine.
[224] Sandeep Vijan,et al. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. , 2005, Diabetes care.
[225] D. Levy,et al. Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression , 2005, Circulation.
[226] Ali H. Mokdad,et al. State of Disparities in Cardiovascular Health in the United States , 2005, Circulation.
[227] L. Becker,et al. Impact of a Community-Based Multiple Risk Factor Intervention on Cardiovascular Risk in Black Families With a History of Premature Coronary Disease , 2005, Circulation.
[228] E. Faglia,et al. Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study. , 2005, American heart journal.
[229] M. Bots,et al. Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response. , 2005, European heart journal.
[230] M. Nieminen,et al. Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study , 2005, Hypertension.
[231] R. Gibbons,et al. Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging. , 2005, Journal of the American College of Cardiology.
[232] E. Vicaut,et al. Design, Baseline Characteristics and Carotid Intima-Media Thickness Reproducibility in the PARC Study , 2005, Cerebrovascular Diseases.
[233] E. Benjamin,et al. Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women. , 2004, The American journal of cardiology.
[234] Michael S Lauer,et al. Left ventricular hypertrophy: the next treatable, silent killer? , 2004, JAMA.
[235] M. Nieminen,et al. Prognostic significance of left ventricular mass change during treatment of hypertension. , 2004, JAMA.
[236] M. Nieminen,et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. , 2004, JAMA.
[237] W S Kerwin,et al. Differentiation of Intraplaque Versus Juxtaluminal Hemorrhage/Thrombus in Advanced Human Carotid Atherosclerotic Lesions by In Vivo Magnetic Resonance Imaging , 2004, Circulation.
[238] C. Yuan,et al. Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRI , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[239] C. Meisinger,et al. Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany , 2004, Circulation.
[240] M. Lauer,et al. Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program. , 2004, JAMA.
[241] Neil R. Powe,et al. Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus , 2004, Annals of Internal Medicine.
[242] N. Day,et al. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.
[243] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[244] L. Wilkins. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .
[245] D. Berman,et al. Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography. , 2004, Journal of the American College of Cardiology.
[246] M. Munafo,et al. The genetic basis for smoking behavior: a systematic review and meta-analysis. , 2004, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[247] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[248] A. Iskandrian,et al. Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study). , 2004, The American journal of cardiology.
[249] J. Gillard,et al. Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques. , 2004, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[250] Stefan Störk,et al. Carotid Artery Plaque Burden, Stiffness, and Mortality Risk in Elderly Men: A Prospective, Population-Based Cohort Study , 2004, Circulation.
[251] D. Berman,et al. Gender-based differences in the prognostic value of coronary calcification. , 2004, Journal of women's health.
[252] M. Nieminen,et al. Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients , 2004, Hypertension.
[253] R. D'Agostino,et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. , 2004, Clinical chemistry.
[254] T. Callister,et al. Progression of Coronary Artery Calcium and Risk of First Myocardial Infarction in Patients Receiving Cholesterol-Lowering Therapy , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[255] Ted Gansler,et al. Preventing Cancer, Cardiovascular Disease, and Diabetes: A Common Agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association * † , 2004, Circulation.
[256] R. Kahn,et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for theAmerican Cancer Society, the American Diabetes Association, and the American Heart Association. , 2004, CA: a cancer journal for clinicians.
[257] F. Dati,et al. First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay – Lp(a) SRM 2B , 2004, Clinical chemistry and laboratory medicine.
[258] M. Taskinen,et al. Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresiss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional two tables. Published, JLR Papers in Press, March 1, 2004. DOI 10.1194/jlr.M300395-JLR200 , 2004, Journal of Lipid Research.
[259] Daniel S Berman,et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. , 2004, Journal of the American College of Cardiology.
[260] R. Gibbons,et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. , 2004, American heart journal.
[261] D. Berman,et al. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. , 2004, European heart journal.
[262] B. Howard,et al. Combined Echocardiographic Left Ventricular Hypertrophy and Electrocardiographic ST Depression Improve Prediction of Mortality in American Indians: The Strong Heart Study , 2004, Hypertension.
[263] Vilmundur Gudnason,et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. , 2004, The New England journal of medicine.
[264] J. Murabito,et al. Accuracy of Offspring Reports of Parental Cardiovascular Disease History: The Framingham Offspring Study , 2004, Annals of Internal Medicine.
[265] A. Hofman,et al. Predictive Value of Noninvasive Measures of Atherosclerosis for Incident Myocardial Infarction: The Rotterdam Study , 2004, Circulation.
[266] L. Shaw,et al. Prognostic value of gated myocardial perfusion SPECT , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[267] David A Bluemke,et al. Using MRI to assess aortic wall thickness in the multiethnic study of atherosclerosis: distribution by race, sex, and age. , 2004, AJR. American journal of roentgenology.
[268] J. Knottnerus,et al. cardiovascular morbidity and mortality , 2003 .
[269] Richard B Devereux,et al. Relationship of High and Low Ankle Brachial Index to All-Cause and Cardiovascular Disease Mortality: The Strong Heart Study , 2004, Circulation.
[270] Daniel Levy,et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.
[271] R. Detrano,et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. , 2004, JAMA.
[272] Bruce M Psaty,et al. Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.
[273] P. Ridker,et al. C-reactive protein and the risk of developing hypertension. , 2003, JAMA.
[274] M. Nieminen,et al. Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study , 2003, Annals of Internal Medicine.
[275] M. Budoff,et al. Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions. , 2003, American heart journal.
[276] E. Topol,et al. The rudimentary phase of personalised medicine: coronary risk scores , 2003, The Lancet.
[277] P. Ridker. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial. , 2003, Circulation.
[278] A. Dyer,et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. , 2003, JAMA.
[279] R. Karas,et al. Effects of Statins on Nonlipid Serum Markers Associated with Cardiovascular Disease , 2003, Annals of Internal Medicine.
[280] J. Pankow,et al. Prediction of coronary heart disease in middle-aged adults with diabetes. , 2003, Diabetes care.
[281] Ronald A. Thisted,et al. Exercise Capacity and the Risk of Death in Women: The St James Women Take Heart Project , 2003, Circulation.
[282] D. Mark,et al. Exercise capacity: the prognostic variable that doesn't get enough respect. , 2003, Circulation.
[283] Samia Mora,et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. , 2003, JAMA.
[284] Daniel Levy,et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. , 2003, Archives of internal medicine.
[285] A. Dyer,et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .
[286] W. Koenig,et al. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. , 2003, American journal of epidemiology.
[287] Ayan R Patel,et al. Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude. , 2003, American heart journal.
[288] James D. Thomas,et al. Prediction of mortality in patients without angina: use of an exercise score and exercise echocardiography. , 2003, European heart journal.
[289] Anne L. Martel,et al. Characterization of Complicated Carotid Plaque With Magnetic Resonance Direct Thrombus Imaging in Patients With Cerebral Ischemia , 2003, Circulation.
[290] X. Jouven,et al. Ventricular ectopy after exercise as a predictor of death. , 2003, The New England journal of medicine.
[291] P. Wilson,et al. 34th Bethesda Conference: Task force #1--Identification of coronary heart disease risk: is there a detection gap? , 2003, Journal of the American College of Cardiology.
[292] H. Tunstall-Pedoe,et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.
[293] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[294] P. O'Malley,et al. Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial. , 2003, JAMA.
[295] Sidney C. Smith,et al. MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .
[296] Alessandro Pontillo,et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. , 2003, JAMA.
[297] L. Quinn,et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. , 2003, Journal of the American College of Cardiology.
[298] E. Hawe,et al. Family History is a Coronary Heart Disease Risk Factor in the Second Northwick Park Heart Study , 2003, Annals of human genetics.
[299] R. Detrano,et al. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. , 2003, Diabetes care.
[300] M. Lauer,et al. Frequent ventricular ectopy after exercise as a predictor of death. , 2003, The New England journal of medicine.
[301] R. Morin,et al. Radiation dose in computed tomography of the heart. , 2003, Circulation.
[302] S. Ebrahim,et al. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? , 2003, International journal of epidemiology.
[303] Muin J Khoury,et al. Research priorities for evaluating family history in the prevention of common chronic diseases. , 2003, American journal of preventive medicine.
[304] D. Bowen,et al. Family history of diabetes as a potential public health tool. , 2003, American journal of preventive medicine.
[305] Yu-ling,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.
[306] Sankey V. Williams,et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). , 2003, Circulation.
[307] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[308] R. Weissleder,et al. In Vivo Imaging of Thrombin Activity in Experimental Thrombi With Thrombin-Sensitive Near-Infrared Molecular Probe , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[309] S. De Cosmo,et al. Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test. , 2002, European journal of endocrinology.
[310] Robert Detrano,et al. Combined Use of Computed Tomography Coronary Calcium Scores and C-Reactive Protein Levels in Predicting Cardiovascular Events in Nondiabetic Individuals , 2002, Circulation.
[311] E. Ford. Does Exercise Reduce Inflammation? Physical Activity and C-Reactive Protein Among U.S. Adults , 2002, Epidemiology.
[312] Stuart R. Lipsitz,et al. Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function? , 2002, Heart.
[313] P. Ridker,et al. Soluble Intercellular Adhesion Molecule-1, Soluble Vascular Adhesion Molecule-1, and the Development of Symptomatic Peripheral Arterial Disease in Men , 2002, Circulation.
[314] F. Coppi,et al. Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. , 2002, Journal of the American College of Cardiology.
[315] L. Cupples,et al. Genetic variability of adult body mass index: a longitudinal assessment in framingham families. , 2002, Obesity research.
[316] V. Fuster,et al. MRI and Characterization of Atherosclerotic Plaque: Emerging Applications and Molecular Imaging , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[317] Paul M. Ridker,et al. Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death , 2002, Circulation.
[318] Colleen M McBride,et al. Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[319] R. D'Agostino,et al. Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study. , 2002, Diabetes care.
[320] S. Grundy,et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary Conference Proceeding for Healthcare Professionals From a Special Writing Group of the American Heart Association , 2002, Circulation.
[321] J. Roseman,et al. Absence of risk factor change in young adults after family heart attack or stroke: the CARDIA Study. , 2002, American journal of preventive medicine.
[322] R. Gibbons,et al. Prognostic value of the Duke treadmill score in the elderly. , 2002, Journal of the American College of Cardiology.
[323] R. Balaban,et al. Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results. , 2002, Radiology.
[324] Victor F. Froelicher,et al. Exercise capacity and mortality among men referred for exercise testing. , 2002, The New England journal of medicine.
[325] A. Nicolaides,et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study(1)). , 2002, Atherosclerosis.
[326] F. Hobbs,et al. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study , 2002, BMJ : British Medical Journal.
[327] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.
[328] F. Paccaud,et al. Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques. , 2002, Preventive medicine.
[329] P. Schnohr,et al. Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study. , 2002, European heart journal.
[330] G. Assmann,et al. Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.
[331] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[332] Chun Yuan,et al. Identification of Fibrous Cap Rupture With Magnetic Resonance Imaging Is Highly Associated With Recent Transient Ischemic Attack or Stroke , 2002, Circulation.
[333] V F Froelicher,et al. Heart rate recovery: validation and methodologic issues. , 2001, Journal of the American College of Cardiology.
[334] A. Maggioni,et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. , 2001, Journal of the American College of Cardiology.
[335] M. Safar,et al. Aortic Pulse Wave Velocity Predicts Cardiovascular Mortality in Subjects >70 Years of Age , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[336] S M Grundy,et al. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.
[337] S. Yusuf,et al. Reduction of Cardiovascular Risk by Regression of Electrocardiographic Markers of Left Ventricular Hypertrophy by the Angiotensin-Converting Enzyme Inhibitor Ramipril , 2001, Circulation.
[338] R. Devereux,et al. Effects of Once-Daily Angiotensin-Converting Enzyme Inhibition and Calcium Channel Blockade-Based Antihypertensive Treatment Regimens on Left Ventricular Hypertrophy and Diastolic Filling in Hypertension: The Prospective Randomized Enalapril Study Evaluating Regression of Ventricular Enlargement (PR , 2001, Circulation.
[339] A Z Faranesh,et al. Attenuated Myocardial Vasodilator Response in Patients With Hypertensive Hypertrophy Revealed by Oxygenation-Dependent Magnetic Resonance Imaging , 2001, Circulation.
[340] V. Fuster,et al. Clinical Imaging of the High-Risk or Vulnerable Atherosclerotic Plaque , 2001, Circulation research.
[341] E. Ashley,et al. An evidence-based review of the resting electrocardiogram as a screening technique for heart disease. , 2001, Progress in cardiovascular diseases.
[342] J. Buring,et al. Maternal and Paternal History of Myocardial Infarction and Risk of Cardiovascular Disease in Men and Women , 2001, Circulation.
[343] J. Manson,et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. , 2001, JAMA.
[344] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[345] A. D. Cunningham,et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population , 2001, Heart.
[346] A. Nicolaides,et al. Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study) , 2001 .
[347] V. Froelicher,et al. Clinical utility of the exercise ECG in patients with diabetes and chest pain. , 2001, Chest.
[348] T. Marteau,et al. Genetic risk and behavioural change , 2001, BMJ : British Medical Journal.
[349] R. Prineas,et al. Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple risk factor intervention trial. , 2001, Journal of electrocardiology.
[350] B. Howard,et al. Computerized ST Depression Analysis Improves Prediction of All‐Cause and Cardiovascular Mortality: The Strong Heart Study , 2001, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[351] P. Ridker,et al. Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. , 2001, Clinical chemistry.
[352] A Camerini,et al. [Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[353] T. Mazzone,et al. Increased prevalence of significant coronary artery calcification in patients with diabetes. , 2001, Diabetes care.
[354] M. Province,et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). , 2001, The American journal of cardiology.
[355] G. Lowe,et al. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. , 2000, The New England journal of medicine.
[356] Anita L. DeStefano,et al. Evidence for a Gene Influencing Blood Pressure on Chromosome 17: Genome Scan Linkage Results for Longitudinal Blood Pressure Phenotypes in Subjects From the Framingham Heart Study , 2000, Hypertension.
[357] K. Yano,et al. Ankle/brachial blood pressure in men >70 years of age and the risk of coronary heart disease. , 2000, The American journal of cardiology.
[358] B. Gersh,et al. Prognostic Value of Treadmill Exercise Testing in Elderly Persons , 2000, Annals of Internal Medicine.
[359] J. Gardin,et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.
[360] M. Lauer,et al. Heart Rate Recovery after Submaximal Exercise Testing as a Predictor of Mortality in a Cardiovascularly Healthy Cohort , 2000, Annals of Internal Medicine.
[361] I. Hertz-Picciotto,et al. Family risk score of coronary heart disease (CHD) as a predictor of CHD: the atherosclerosis risk in communities (ARIC) study and The NHLBI Family Heart Study , 2000, Genetic epidemiology.
[362] T. Fahey,et al. Estimation of cardiovascular risk in hypertensive patients in primary care. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.
[363] R B D'Agostino,et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. , 2000, American heart journal.
[364] M. Lauer,et al. Heart-rate recovery immediately after exercise as a predictor of mortality. , 1999, The New England journal of medicine.
[365] J. Kampert,et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. , 1999, JAMA.
[366] T D Miller,et al. Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG. , 1999, JAMA.
[367] G. Habib,et al. Silent myocardial ischemia in patients with diabetes: who to screen. , 1999, Diabetes care.
[368] H. Cohen,et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. , 1999, The American journal of medicine.
[369] I Vuori,et al. Public health burden of coronary heart disease risk factors among middle-aged and elderly men. , 1999, Preventive medicine.
[370] Enrique Sanchez-Delgado,et al. Lifetime risk of developing coronary heart disease , 1999, The Lancet.
[371] N. Powe,et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[372] P M Okin,et al. Impaired chronotropic response to exercise stress testing as a predictor of mortality. , 1999, JAMA.
[373] A. Dyer,et al. Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study. , 1999, JAMA.
[374] R. Kronmal,et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. , 1999, The New England journal of medicine.
[375] G. De Backer,et al. Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women , 1998, Heart.
[376] M. Cirillo,et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. , 1998, Archives of internal medicine.
[377] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[378] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[379] S. Grundy,et al. Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. , 1998, Circulation.
[380] R H Selzer,et al. The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.
[381] A. Folsom,et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. , 1997, American journal of epidemiology.
[382] Arno W. Hoes,et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. , 1997, Circulation.
[383] C. la Vecchia,et al. Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction. Argentine FRICAS (Factores de Riesgo Coronario en America del Sur) Investigators. , 1997, The American journal of cardiology.
[384] D. Reda,et al. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. , 1997, Circulation.
[385] A. Lee,et al. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study , 1996, BMJ.
[386] L. Kuller,et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[387] P M Okin,et al. Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. , 1996, Circulation.
[388] R. Califf,et al. 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 5. Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. , 1996, Journal of the American College of Cardiology.
[389] M. Mayo-Smith,et al. Differences in Generalists' and Cardiologists' Perceptions of Cardiovascular Risk and the Outcomes of Preventive Therapy in Cardiovascular Disease , 1996, Annals of Internal Medicine.
[390] J. Gardin,et al. Subclinical disease as an independent risk factor for cardiovascular disease. , 1995, Circulation.
[391] M. Abrahamowicz,et al. Do doctors accurately assess coronary risk in their patients? Preliminary results of the coronary health assessment study , 1995, BMJ.
[392] M. Kornitzer,et al. Ankle/Arm Pressure Index in Asymptomatic Middle-Aged Males: An Independent Predictor of Ten-Year Coronary Heart Disease Mortality , 1995, Angiology.
[393] R. Prineas,et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS). , 1995, Circulation.
[394] G. Thorgeirsson,et al. Unrecognized Myocardial Infarction: Epidemiology, Clinical Characteristics, and the Prognostic Role of Angina Pectoris: The Reykjavik Study , 1995, Annals of Internal Medicine.
[395] M. Hori,et al. Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.
[396] D. Rogers,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus , 1994 .
[397] L. Berkman,et al. Genetic susceptibility to death from coronary heart disease in a study of twins. , 1994, The New England journal of medicine.
[398] J. Murray,et al. Guidelines for electrocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Electrocardiography). , 1992, Journal of the American College of Cardiology.
[399] R. Langer,et al. Mortality over a period of 10 years in patients with peripheral arterial disease. , 1992, The New England journal of medicine.
[400] F. Harrell,et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. , 1991, The New England journal of medicine.
[401] D E Manyari,et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. , 1990, The New England journal of medicine.
[402] H. Huikuri,et al. Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients. , 1990, British heart journal.
[403] R. Detrano,et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. , 1989, Circulation.
[404] David A. Gerber,et al. Predictive value of clinical and exercise variables for detection of coronary artery disease in men with diabetes mellitus. , 1987, The American journal of cardiology.
[405] W. Kannel,et al. Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. , 1984, The New England journal of medicine.
[406] P. Magnus,et al. A comparison of populations self-selected and randomly selected for coronary risk factor screening. , 1983, Preventive medicine.
[407] W. Koenig,et al. Predicting the Risk of Cardiovascular Disease , 2012, Molecular Diagnosis & Therapy.
[408] E. Boerwinkle,et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities ( ARIC ) study , 2010 .
[409] Hanyu Ni,et al. Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.
[410] S. Schinner. Effects of Intensive Glucose Lowering in Type 2 Diabetes , 2009 .
[411] R. Shephard,et al. Ethnic Differences in Left Ventricular Remodeling in Highly-Trained Athletes: Relevance to Differentiating Physiologic Left Ventricular Hypertrophy From Hypertrophic Cardiomyopathy , 2009 .
[412] Alexander Becker,et al. Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals. , 2008, American heart journal.
[413] L. Becker,et al. Sustainability of a multiple risk factor intervention on cardiovascular disease in high-risk African American families. , 2008, Ethnicity & disease.
[414] S. Dharmage,et al. HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review. , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[415] A. Folsom,et al. Bmc Cardiovascular Disorders the Association of the Ankle-brachial Index with Incident Coronary Heart Disease: the Atherosclerosis Risk in Communities (aric) Study, 1987–2001 , 2022 .
[416] G. Berglund,et al. The Epidemiology of LpPLA 2 : Distribution and Correlation with Cardiovascular Risk Factors in a Population-based Cohort , 2006 .
[417] Jeroen J. Bax,et al. Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: Combined use of stress myocardial perfusion imaging and coronary calcium scoring , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[418] M. Budoff,et al. Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women. , 2006, Atherosclerosis.
[419] P. Greenland,et al. Coronary computed tomography in coronary risk assessment. , 2005, Journal of cardiopulmonary rehabilitation.
[420] Ian G. Harnik. Heart-rate profile during exercise as a predictor of sudden death. , 2005, The New England journal of medicine.
[421] Screening for coronary heart disease: recommendation statement. , 2004, Annals of internal medicine.
[422] Anne L. Taylor,et al. Evidence-based guidelines for cardiovascular disease prevention in women. , 2004, Journal of the American College of Cardiology.
[423] A. Mokdad,et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.
[424] D. Berman,et al. Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease , 2002, Circulation.
[425] G. De Backer,et al. Electrocardiographic findings and global coronary risk assessment. , 2002, European heart journal.
[426] M. Lauer. Clinical practice. Aspirin for primary prevention of coronary events. , 2002, The New England journal of medicine.
[427] Ose,et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events* , 2002 .
[428] Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. , 2002, Circulation.
[429] E. Antman,et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). , 2002, Circulation.
[430] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[431] Eary,et al. CAROTID-ARTERY INTIMA AND MEDIA THICKNESS AS A RISK FACTOR FOR MYOCARDIAL INFARCTION AND STROKE IN OLDER ADULTS , 2000 .
[432] S. Grundy,et al. AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association. , 2000, Circulation.
[433] R. Schmieder,et al. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. , 1996, JAMA.
[434] K. Anderson,et al. An updated coronary risk profile. A statement for health professionals. , 1991, Circulation.
[435] S C Hunt,et al. A comparison of positive family history definitions for defining risk of future disease. , 1986, Journal of chronic diseases.
[436] W. Kannel,et al. Diabetes and cardiovascular disease. The Framingham study. , 1979, JAMA.
[437] W. Kannel,et al. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. , 1970, Annals of internal medicine.
[438] Takuya Yamazaki,et al. Prognostic Significance of Quantitative Qrs Duration , 2022 .